Implantica to host Capital Markets Day in Stockholm on September 9
Medtech company Implantica AG (publ.) will host a Capital Markets Day in Stockholm on September 9. The event will focus on presenting the company's strategy and future outlook.
Liechtenstein-based medtech company Implantica AG (publ.) will host its Capital Markets Day in Stockholm on September 9. During the event, the company's management will present Implantica's business strategy, technological advancements, and future growth opportunities.
The company is particularly known for its RefluxStop® device, designed for the treatment of acid reflux, a condition affecting an estimated one billion people worldwide. Implantica aims to introduce advanced technology for internal body treatments.
The Capital Markets Day will provide investors and other stakeholders with an opportunity to gain a deeper understanding of the company's business model and its market potential. The meeting is expected to offer clarity on Implantica's future plans and capital requirements.
The event in Stockholm will gather key company representatives, analysts, and investors to discuss the company's development and its positioning within the medtech market.